Sabin Nsanzimana Selected Research

Sabin Nsanzimana Research Topics

7	Infections 01/2022 - 01/2017
5	Chronic Hepatitis C 01/2022 - 01/2019
5	HIV Infections (HIV Infection) 11/2018 - 01/2015
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
3	Hepatitis C 06/2020 - 01/2017
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 10/2015
2	COVID-19 01/2022 - 01/2021
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2017 - 11/2016
1	Febrile Seizures (Febrile Seizure) 07/2022
1	Gastroenteritis 07/2022
1	Fever (Fevers) 07/2022
1	Hyperglycemia 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Noncommunicable Diseases 01/2021
1	Heart Failure 01/2021
1	Rubella (German Measles) 01/2016
1	Measles 01/2016
1	Communicable Diseases (Infectious Diseases) 10/2015
1	Syphilis 02/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015

6	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
3	VaccinesIBA 07/2022 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2017 - 01/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 07/2022
1	Monoclonal AntibodiesIBA 01/2022
1	favipiravirIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 01/2022
1	SofosbuvirIBA 01/2022
1	velpatasvirIBA 01/2022
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2021
1	sofosbuvir drug combination ledipasvirIBA 01/2019
1	Viral RNAIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	HIV AntibodiesIBA 11/2015
1	ReaginsIBA 02/2015
1	SolutionsIBA 01/2015
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2015

5	Therapeutics 01/2022 - 11/2016
2	Condoms (Condom) 10/2017 - 11/2016
1	Ambulatory Care (Outpatient Care) 01/2021
1	Chemoprevention 10/2015
1	Art Therapy 01/2015